Astrazeneca Plc ADR (AZN)

Mar 31, 2025, 2:30 PM EDT - 5 hours ago

Pharma tariffs the 'number one question' on investors' minds, Barclays says

GSK NVO NVS

Mar 27, 2025, 3:20 PM EDT - 4 days ago

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

BBIO

Mar 26, 2025, 9:00 AM EDT - 5 days ago

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

Mar 21, 2025, 12:30 PM EDT - 10 days ago

AstraZeneca CEO on its $2.5 billion investment in Beijing hub

Mar 21, 2025, 9:25 AM EDT - 10 days ago

AstraZeneca to Invest $2.5 Billion in China Amid Probes

Mar 21, 2025, 9:21 AM EDT - 10 days ago

Watch CNBC's full interview with AstraZeneca CEO Pascal Soriot

Mar 21, 2025, 8:55 AM EDT - 10 days ago

Watch CNBC's full interview with Pascal Soriot, AstraZeneca CEO

Mar 21, 2025, 7:21 AM EDT - 10 days ago

Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies

Mar 21, 2025, 7:10 AM EDT - 10 days ago

British pharma giant AstraZeneca to invest $2.5 billion in new China hub

Mar 21, 2025, 7:03 AM EDT - 10 days ago

AstraZeneca investing $2.5 bln in China as drugmaker seeks to recover from scandals

Mar 19, 2025, 8:00 AM EDT - 12 days ago

Mindpeak to deploy and evaluate AI-Powered Digital Pathology Risk Assessment Tools for Breast Cancer in collaboration with AstraZeneca

Mar 17, 2025, 8:04 AM EDT - 14 days ago

IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals

Mar 17, 2025, 5:45 AM EDT - 14 days ago

AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy'

Mar 17, 2025, 3:47 AM EDT - 14 days ago

AstraZeneca Buys EsoBiotec for Up to $1 Billion

Mar 17, 2025, 3:07 AM EDT - 14 days ago

AstraZeneca to buy Esobiotec for upto $1 billion

Mar 17, 2025, 3:00 AM EDT - 14 days ago

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition

Mar 14, 2025, 6:08 PM EDT - 17 days ago

Drugmakers agree to participate in second round of price negotiations

ABBV GSK MRK NVO TEVA

Mar 14, 2025, 12:00 PM EDT - 17 days ago

AstraZeneca and Erin Andrews team up to inspire fans to Get Body Checked Against Cancer

Mar 5, 2025, 6:25 PM EST - 26 days ago

6 Ideal Buys From 14 'Safer' March Dividends On Bloomberg 2025 Watch List Of 50

AVGO CL EL EMR FOX HSBC KLAC

Mar 5, 2025, 7:00 AM EST - 26 days ago

AstraZeneca: A Big Pharma Blue Chip To Buy Now

Mar 4, 2025, 5:31 AM EST - 27 days ago

2025 Endothelin Receptor Antagonist Pipeline Insights for 10+ Companies and 15+ Pipeline Drugs, Including Zibotentan (AstraZeneca), SC0062 (Biocity Biopharmaceutics), and GMA301 (Gmax Biopharm)

Mar 3, 2025, 8:00 AM EST - 4 weeks ago

ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY-Gastric04 Phase 3 Trial

Mar 1, 2025, 5:30 PM EST - 4 weeks ago

Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

Feb 28, 2025, 10:01 AM EST - 4 weeks ago

EU backs AstraZeneca, Daiichi's Enhertu for breast cancer treatment post endocrine therapy

Feb 28, 2025, 7:24 AM EST - 4 weeks ago

Neurofibromatoses Therapeutics Competitive Landscape Report 2024: Pipeline Holds 35 Molecules - Currently Only 1 Approved Innovator Drug, AstraZeneca's (Koselugo/Coselugo) Selumetinib Sulfate

Feb 27, 2025, 2:30 AM EST - 4 weeks ago

BioInvent International AB: Year-End Report January 1 - December 31, 2024

Feb 26, 2025, 7:00 AM EST - 4 weeks ago

Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

Feb 26, 2025, 2:19 AM EST - 4 weeks ago

AstraZeneca therapy improves survival in late-stage breast cancer trial

Feb 25, 2025, 1:20 PM EST - 4 weeks ago

Final Trades: Starbucks, Astrazeneca, Western Union and the IYR

SBUX WU IYR

Feb 24, 2025, 4:00 AM EST - 5 weeks ago

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

SOPH

Feb 20, 2025, 3:56 PM EST - 5 weeks ago

Final Deadline for the AstraZeneca PLC Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - AZN

Feb 20, 2025, 3:00 PM EST - 5 weeks ago

AstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4B as Firm Expands Cancer Pipeline

Feb 20, 2025, 1:25 PM EST - 5 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca PLC Lawsuit – AZN

Feb 20, 2025, 1:08 PM EST - 5 weeks ago

Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million

FGEN

Feb 20, 2025, 6:40 AM EST - 5 weeks ago

FibroGen sells China unit to AstraZeneca in deal worth $160 million

FGEN

Feb 19, 2025, 1:00 PM EST - 5 weeks ago

AstraZeneca Post 2024 Earnings: Unwanted Headwinds Warrant Downgrade To Hold

Feb 19, 2025, 11:23 AM EST - 5 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Feb 16, 2025, 9:24 AM EST - 6 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca

Feb 14, 2025, 12:32 PM EST - 6 weeks ago

AstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens Berman